Losing neurofibromin is good news for breast cancer
It is well known that neurofibromin (NF1), a tumor suppressor produced by the NF1 gene, keeps cancer growth in check by repressing the activity of
Read More
From The Labs
From my perspective: Dr. Ethan Roy shares his experiences as a graduate student at Baylor
From the Labs interviewed Dr. Ethan Roy to learn about his challenging beginnings in the lab, his fascination with neurodegenerative diseases and his plans to
Read More
From the labs to bedside: Genomics can drive precision medicine
You can’t escape your genetics, but with a little help, you can be proactive and intervene. That is why researchers at Baylor College of Medicine’s Human
Read More
AKAP8 and the delicate balance between normal and metastatic states
A protein naturally produced in the body has been found to suppress breast cancer metastasis in animal models of human tumors. “Our laboratory investigates cellular
Read More
Like a mastermind of its own destiny, glioma sets a stage that favors its own growth
“In some regards, glioma brain tumors exhibit Machiavellian behavior,” said Dr. Benjamin Deneen. Machiavellian, as in scheming and cunning, comes from the Italian philosopher Niccolò
Read More
Connecting interferon, neuroinflammation and synapse loss in Alzheimer’s disease
When immunologist Dr. Wei Cao joined Baylor College of Medicine three-and-a-half years ago, her first project was to investigate how inflammation contributes to Alzheimer’s disease.
Read More
IMAGE OF THE MONTH: Layers of blood vessels in the retina
The image this month shows the three vascular layers of the retina that are important for normal visual function. Vision begins in the retina,
Read More
It’s Heart Month!
From the Labs wraps up Heart Month highlighting a selection of posts about heart-related research at Baylor. The following articles posted in 2019 reveal novel
Read More
Congratulations to the recipients of CPRIT grants for cancer research!
Baylor College of Medicine has been awarded nearly $2.7 million by the Cancer Prevention and Research Institute of Texas (CPRIT) to support new cancer research.
Read More
An unprecedented look at endometrial cancer
Which therapy will benefit this particular patient the most? Dr. Bing Zhang and his colleagues offer insights that might help physicians better answer this question
Read More